Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$56.4M |
| 2 |
Chemed
CHE
|
+$53.8M |
| 3 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$53.1M |
| 4 |
Petrobras
PBR
|
+$52.7M |
| 5 |
FIEG
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMER
FIRSTMERIT CORP
FMER
|
+$58.7M |
| 2 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$38.2M |
| 3 |
PL
PROTECTIVE LIFE CORP
PL
|
+$37.8M |
| 4 |
Sally Beauty Holdings
SBH
|
+$36.2M |
| 5 |
TSMC
TSM
|
+$35.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.31% |
| 2 | Financials | 20.61% |
| 3 | Healthcare | 14.68% |
| 4 | Technology | 12.41% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$337B
| $638M | 1.36% |
7,622,502
+29,184
| +0.4% | +$2.39M |
|
|
NVO
27
Novo Nordisk
NVO
$190B
| $637M | 1.36% |
26,771,826
-711,232
| -3% | -$16.4M |
|
28
Citigroup
C
$233B
| $608M | 1.3% |
11,725,663
+42,816
| +0.4% | +$2.15M |
|
29
Novartis
NVS
$261B
| $566M | 1.21% |
6,713,000
+50,521
| +0.8% | +$4.09M |
|
30
Toyota
TM
$235B
| $558M | 1.19% |
4,748,467
+32,596
| +0.7% | +$3.84M |
|
|
FBGX
31
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
| $553M | 1.18% |
5,316,800
+513,767
| +11% | +$53.1M |
|
32
GSK
GSK
$96.4B
| $528M | 1.13% |
9,190,875
+98,153
| +1% | +$6.02M |
|
|
FLGE
33
DELISTED
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
| $515M | 1.1% |
4,961,809
-41,280
| -0.8% | -$4.26M |
|
34
Royal Bank of Canada
RY
$285B
| $482M | 1.03% |
6,743,019
+21,230
| +0.3% | +$1.56M |
|
35
PepsiCo
PEP
$186B
| $475M | 1.01% |
5,106,124
+51,515
| +1% | +$4.7M |
|
|
SI
36
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $455M | 0.97% |
3,816,829
+148,667
| +4% | +$17.7M |
|
37
SAP
SAP
$238B
| $436M | 0.93% |
6,041,627
+30,974
| +0.5% | +$2.41M |
|
38
Coca-Cola
KO
$380B
| $433M | 0.92% |
10,138,859
+63,063
| +0.6% | +$2.61M |
|
39
Oracle
ORCL
$433B
| $427M | 0.91% |
11,147,554
-1,958
| -0% | -$79.3K |
|
40
SLB Ltd
SLB
$83.2B
| $424M | 0.9% |
4,165,444
-3,028
| -0.1% | -$330K |
|
41
Chevron
CVX
$420B
| $419M | 0.89% |
3,509,587
+5,507
| +0.2% | +$703K |
|
42
ExxonMobil
XOM
$683B
| $416M | 0.89% |
4,425,415
-38,451
| -0.9% | -$3.83M |
|
43
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11.3B
| $415M | 0.88% |
13,506,337
+576,421
| +4% | +$17.7M |
|
|
44
TSMC
TSM
$2.25T
| $403M | 0.86% |
19,979,699
-1,709,181
| -8% | -$35.6M |
|
45
Merck
MRK
$355B
| $387M | 0.83% |
6,847,082
+72,555
| +1% | +$4.07M |
|
46
Cisco
CSCO
$442B
| $380M | 0.81% |
15,110,780
+2,874
| +0% | +$72.3K |
|
|
BAY
47
DELISTED
BAYER AG SPONS ADR
BAY
| $352M | 0.75% |
2,511,364
+208,995
| +9% | +$29.3M |
|
|
BF
48
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $284M | 0.61% |
3,099,728
+13,956
| +0.5% | +$1.28M |
|
49
iShares MBS ETF
MBB
$38.9B
| $273M | 0.58% |
2,523,978
+97,909
| +4% | +$10.6M |
|
50
HDFC Bank
HDB
$120B
| $264M | 0.56% |
22,682,496
-377,604
| -2% | -$4.58M |
|
Similar funds
Ken Fisher's Q3 2014 Portfolio in Review
As of Q3 2014, Ken Fisher held 645 positions worth $46.9B, down 1.4% from $47.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q3 2014 filing shows 47 new, 202 increased, 264 reduced and 61 closed positions. Its largest new stake was Chemed: 530,910 shares worth $54.6M. The largest sale was FIRSTMERIT CORP, an estimated $58.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2014 buy was Chemed: 530,910 shares worth $54.6M.
- Ken Fisher added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2014, an estimated $56.4M increase.
- Ken Fisher's biggest Q3 2014 reduction was FIRSTMERIT CORP, cutting an estimated $58.7M.
- Ken Fisher fully exited PROTECTIVE LIFE CORP in Q3 2014, selling an estimated $37.8M.
- Ken Fisher's ten largest holdings make up 22% of its $46.9B portfolio in Q3 2014.
- Ken Fisher opened 47 new positions and closed 61 in Q3 2014.
- Ken Fisher's portfolio value fell 1.4% quarter-over-quarter to $46.9B.
Based on Fisher Asset Management's 13F filing for Q3 2014, filed 20 Oct 2014.